Author:
Salminen L.,Lindberg R.,Toivari H. -R.,Huupponen R.,Kaila T.,Iisalo E.
Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. Alvan G, von Bahr C, Seideman P, Sjöqvist F. High plasma concentrations of β-receptor blocking drugs and deficient debrisoquine hydroxylation. Lancet 1: 333, 1982
2. Bergamini MVW. The metabolic mechanisms affecting drug actions in the eye. In Drace SM, Neufeld AH (eds) Glaucoma: Applied pharmacology in medical treatment. Grune & Stratton, Inc. Toronto pp 151–184, 1984
3. Eichelbaum M. Polymorphic drug oxidation in humans. Fed Proc 43: 2298–2302, 1984
4. Evans DAP. Genetic studies involving drug metabolism in man. In: Gorrod JW, Beckett AH (eds) Drug Metabolism in Man. Taylor and Francis, London pp 135–155, 1978
5. Evans DAP, Mahgoub A, Sloan TP, Idle JR, Smith RL. A family and population study of genetic polymorphism of debrisoquine oxidation in a white British population. J Med Genet 17: 102–105, 1980
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献